Merck & Co., Inc.'s Shingles Vaccine Not Reaching Enough U.S. Adults

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Too few American adults have been vaccinated for shingles, the painful sibling to chicken pox, according to research that calls for efforts to increase the U.S.-recommended inoculation. Fewer than 2 of 10 Americans ages 60 and older have been vaccinated, while the rate is less than half that for those in their 50s, according to a study presented today at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver. Almost one-third of Americans will get shingles in their lifetime, with about 1 million cases in the U.S. each year, the Centers for Disease Control and Prevention said.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC